CRP and viral load: A novel assay called MeMed BV that integrates measurements of blood-borne host-proteins (tumour necrosis factor-related apoptosis-inducing ligand, interferon γ-induced protein-10, and CRP) was developed and manufactured by MeMed Diagnostics (Tirat Carmel, Israel) to assist in differentiation between bacterial and viral disease [83,89].